Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Ronald W. Penczek

At a glance: Ronald W. Penczek is Cao & Controller at Elevance Health (ELV). Their latest SEC Form 4, filed Jun 15, 2026, reported a sale of $149K. On file: 0 purchase lines ($0) and 2 sale lines ($766K).

Disclosed holdings: about $1.5M of ELV stock: 3,740 shares reported on their latest Form 4 (filed Jun 15, 2026), valued at the Nov 19, 2026 close of $391.13. This counts only ELV shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Cao & Controller at Elevance Health, Inc. (ELV)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $766K

Ronald W. Penczek's InsiderPrint

2 trades from SEC Form 4 filings, 2026 to 2026, drawn as one fingerprint.

InsiderPrint of Ronald W. Penczek: 2 trades, 2026 to 20262026: 0 buys, 2 sales
  • Bump outward: a purchase (0)
  • Dent inward: a sale (2)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Reported trades

Filed Stock Type Shares Price Value Since
Jun 15SEC ELVElevance Health, Inc. Sell 3693,740 held (−9%) $403.16 $149K -3.0%
May 20SEC ELVElevance Health, Inc. Sell 1,5314,109 held (−27%) $403.13 $617K -3.0%
  • Sell

    Cao & Controller Ronald W Penczek sold $617K of ELV at $403.13 — cuts the stake by 27%.

Follow Ronald W. Penczek

Get one email when Ronald W. Penczek files a new purchase or sale. Free.

At most one email a day about Ronald W. Penczek, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.